Teva-Mylan Deal Gains Traction As Perrigo Deal Is Rejected
Israel's Teva Pharmaceuticals Ltd. on Tuesday morning launched an $82 per share bid to take over Pennsylvania-based Mylan NV, a proposal with an enterprise value of $50 billion, just hours before...To view the full article, register now.
Already a subscriber? Click here to view full article